Apt Therapeutics, Inc.

Biotechnology company · Saint Louis, Missouri, United States

Apt Therapeutics, Inc. is a biotechnology company headquartered in Saint Louis, Missouri, United States. It has received 33 US government small-business research awards (SBIR/STTR) from health agencies, $25 million in total, most recently in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Apt Therapeutics at a glance

Typebiotechnology company

HeadquartersSaint Louis, Missouri, United States

What does Apt Therapeutics do?

US government research funding

33 SBIR/STTR small-business research awards from US health agencies, $25.1 million in total (2004 to 2023). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Apt Therapeutics

Where is Apt Therapeutics headquartered?

Apt Therapeutics, Inc. is headquartered in Saint Louis, Missouri, United States.

What does Apt Therapeutics do?

Apt Therapeutics, Inc. is a biotechnology company.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences